Sovereign Pharma dispatches first batch of Remdesivir injections to Cipla

The Daman-based Sovereign Pharma is manufacturing the antiviral drug for Indian pharmaceutical giant Cipla, as it continues to be one of the few effective ways to combat Covid-19. Established in 2003 as a contract manufacturing organization (CMO) to produce high-quality injectables for pharmaceutical companies worldwide, Sovereign now produces 350 million pieces each year. It sells over one billion injections by the number of doses every year. As Indian medical authorities and the pharma industry are working relentlessly to provide medications to treat Coronavirus, Sovereign Pharma announced the dispatch of its first batch of Remdesivir injections for Cipla on 7 July 2020. Sovereign Pharma dispatches the first batch of Remdesivir In the absence of a definitive treatment line, the Indian government under the guidance of prime minister Narendra Modi has been instrumental in encouraging local drug manufacturers to identify potential treatments for the virus and ramp up production of the existing medications. Within the union territory of Daman and Diu, one of India’s pharmaceutical hubs, Sovereign Pharma has prepared the first batch of Remdesivir within record…

Choose your subscription to read more